Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Diet’s role in fighting vitiligo highlighted in new research March 13, 2024 Skipping breakfast has little impact on mental performance, research shows November 3, 2025 Study identifies key neurons controlling threat response and escape in mice June 27, 2024